Beryl Capital Management LLC 13D and 13G filings for Marinus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 12:31 pm Sale | 2025-03-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Beryl Capital Management LLC | 0 0.000% | -5,462,942 (Position Closed) | Filing |
| 2025-01-07 7:15 pm Purchase | 2024-12-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Beryl Capital Management LLC | 5,462,942 9.900% | 5,462,942 (New Position) | Filing |